Obese Patients with Upper GI Bleeds Face More Intensive Care, Higher Health Costs

Marwan S. Abougergi, MD Oral 7 Does Obesity Impact Mortality and Other Outcomes in Patients With Upper Gastrointestinal Hemorrhage? A Nationwide Analysis Author Insight from Marwan S. Abougergi, MD, Catalyst Medical Consulting What’s new ...

Pancreatic Cancer in Urban African Americans- Too Young, Too Late

Saurabh Chawla, MD Oral 9 Pancreatic Cancer in Urban African Americans- Too Young, Too Late Author Insight from Saurabh Chawla MD, Jessica Liu MD, Tabassum Khan, Maria C Russell MD, Grady Memorial Hospital & Emory School of Medicine  What’s ...

Oral 4 Gut Microbiota Changes as Predictors of Treatment Failure in Primary Clostridium Difficile Infection

**EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 19, 2015 at 8 AM (EDT).   Sahil Khanna, MD Oral 4 Gut Microbiota Changes as Predictors of Treatment Failure in Primary ...

Oral 69 Does Cesarean section and formula feeding reduce vertical transmission in chronic hepatitis B pregnant mothers?

**EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 19, 2015 at 8 AM  (EDT). Rasham Mittal, MD Oral 69 Does Cesarean section and formula feeding reduce vertical transmission in ...

Study Suggests All-Oral Therapy for HCV G1 Patients is Highly Effective, Regardless of Race or Ethnicity

Nancy Reau, MD Oral 65 High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/R+dasabuvir+/-Ribavirin: Integrated Safety and Efficacy Analysis Author ...

A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study

  Stephen B. Hanauer, MD, FACG Oral 19 A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study Author ...